相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dopaminergic Therapeutics in Multiple Sclerosis: Focus on Th17-Cell Functions
Mikhail Melnikov et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2020)
Targeting the cholinergic system in Parkinson's disease
Changliang Liu
ACTA PHARMACOLOGICA SINICA (2020)
Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?
Pengfei Yang et al.
AGEING RESEARCH REVIEWS (2020)
Abundance Compensates Kinetics: Similar Effect of Dopamine Signals on D1 and D2 Receptor Populations
Lars Hunger et al.
JOURNAL OF NEUROSCIENCE (2020)
Metabotropic signaling cascade involved in α4β2 nicotinic acetylcholine receptor-mediated PKCβII activation
Srijan Acharya et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)
Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders
Maryka Quik et al.
NICOTINE & TOBACCO RESEARCH (2019)
Alpha7 Nicotinic Receptors as Therapeutic Targets in Schizophrenia
Jason R. Tregellas et al.
NICOTINE & TOBACCO RESEARCH (2019)
α4β2 nicotinic acetylcholine receptor downregulates D3 dopamine receptor expression through protein kinase C activation
Srijan Acharya et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Mitochondria as a possible target for nicotine action
Dominika Malinska et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2019)
Striatal cholinergic interneurons and Parkinson's disease
Asami Tanimura et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2018)
Pharmacokinetic Limitations on Effects of an Alpha7-Nicotinic Receptor Agonist in Schizophrenia: Randomized Trial with an Extended-Release Formulation
William R. Kem et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Unique Molecular Regulation of Higher-Order Prefrontal Cortical Circuits: Insights into the Neurobiology of Schizophrenia
Dibyadeep Datta et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Regional Heterogeneity of D2-Receptor Signaling in the Dorsal Striatum and Nucleus Accumbens
Pamela F. Marcott et al.
NEURON (2018)
Partial Depletion of Peripheral M1 Macrophages Reverses Motor Deficits in MPTP-Treated Mouse by Suppressing Neuroinflammation and Dopaminergic Neurodegeneration
Aijuan Yan et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Role of glutamatergic system and mesocorticolimbic circuits in alcohol dependence
Fawaz Alasmari et al.
PROGRESS IN NEUROBIOLOGY (2018)
Tau Pathology in Parkinson's Disease
Xue Zhang et al.
FRONTIERS IN NEUROLOGY (2018)
The dopamine D3 receptor, a quarter century later
Pierre Sokoloff et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2017)
Microglia and Monocytes/Macrophages Polarization Reveal Novel Therapeutic Mechanism against Stroke
Masato Kanazawa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Detection of phasic dopamine by D1 and D2 striatal medium spiny neurons
Cedric Yapo et al.
JOURNAL OF PHYSIOLOGY-LONDON (2017)
First in human trial of a type I positive allosteric modulator of alpha7-nicotinic acetylcholine receptors: Pharmacokinetics, safety, and evidence for neurocognitive effect of AVL-3288
Kelvin W. Gee et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence
Asti Jackson et al.
NEUROPHARMACOLOGY (2017)
ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study) A Randomized Clinical Trial
Rajesh Pahwa et al.
JAMA NEUROLOGY (2017)
Implication of dorsostriatal D3 receptors in motivational processes: a potential target for neuropsychiatric symptoms in Parkinson's disease
Mathieu Favier et al.
SCIENTIFIC REPORTS (2017)
Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia
Amy F. T. Arnsten et al.
BIOLOGICAL PSYCHIATRY (2017)
A quantitative review of the postmortem evidence for decreased cortical N-methyl-D-aspartate receptor expression levels in schizophrenia: How can we link molecular abnormalities to mismatch negativity deficits?
Vibeke S. Catts et al.
BIOLOGICAL PSYCHOLOGY (2016)
Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration
Hongwei Qin et al.
JOURNAL OF NEUROSCIENCE (2016)
Optogenetic activation of striatal cholinergic interneurons regulates L-dopa-induced dyskinesias
Tanuja Bordia et al.
NEUROBIOLOGY OF DISEASE (2016)
Levodopa therapy for Parkinson disease A look backward and forward
Peter A. LeWitt et al.
NEUROLOGY (2016)
Basal Forebrain Cholinergic Circuits and Signaling in Cognition and Cognitive Decline
Elizabeth C. Ballinger et al.
NEURON (2016)
Cholinergic Mesopontine Signals Govern Locomotion and Reward through Dissociable Midbrain Pathways
Cheng Xiao et al.
NEURON (2016)
Dopamine receptors D3 and D5 regulate CD4+ T-cell activation and differentiation by modulating ERK activation and cAMP production
Dafne Franz et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Deficiency Attenuates Phagocytic Activities of Microglia and Exacerbates Ischemic Damage in Experimental Stroke
Masahito Kawabori et al.
JOURNAL OF NEUROSCIENCE (2015)
Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms
Tamas Roszer
MEDIATORS OF INFLAMMATION (2015)
α7 Nicotinic Receptor Agonists Reduce Levodopa-Induced Dyskinesias With Severe Nigrostriatal Damage
Danhui Zhang et al.
MOVEMENT DISORDERS (2015)
Diversity of native nicotinic receptor subtypes in mammalian brain
Michele Zoli et al.
NEUROPHARMACOLOGY (2015)
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Matthieu F. Bastide et al.
PROGRESS IN NEUROBIOLOGY (2015)
Levetiracetam Ameliorates L-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats Inducing Critical Molecular Changes in the Striatum
Huan Du et al.
PARKINSONS DISEASE (2015)
The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies
Wei Hu et al.
YEAR IN NEUROLOGY AND PSYCHIATRY (2015)
Behavioral-cognitive targets for cholinergic enhancement
Martin Sarter
CURRENT OPINION IN BEHAVIORAL SCIENCES (2015)
Dopamine's Actions in Primate Prefrontal Cortex: Challenges for Treating Cognitive Disorders
Amy F. T. Arnsten et al.
PHARMACOLOGICAL REVIEWS (2015)
Diverse strategies targeting α7 homomeric and α6β2*heteromeric nicotinic acetylcholine receptors for smoking cessation
Darlene H. Brunzell et al.
ADDICTION REVIEWS (2014)
Striatal Cholinergic Cell Ablation Attenuates L-DOPA Induced Dyskinesia in Parkinsonian Mice
Lisa Won et al.
JOURNAL OF NEUROSCIENCE (2014)
ROLE OF NICOTINIC ACETYLCHOLINE RECEPTORS IN REGULATING DOPAMINE NEURON ACTIVITY
P. Faure et al.
NEUROSCIENCE (2014)
New treatments for the motor symptoms of Parkinson's disease
Anne-Catherine Vijverman et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2014)
The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue
Ralf Brisch et al.
FRONTIERS IN PSYCHIATRY (2014)
Cortical control of VTA function and influence on nicotine reward
Jie Wu et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Nicotine dependence in patients with schizophrenia
Aniruddha Basu et al.
BRITISH JOURNAL OF PSYCHIATRY (2013)
Genetics of impulse control disorders in Parkinson's disease
Florence Cormier et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
PPARα Regulates Cholinergic-Driven Activity of Midbrain Dopamine Neurons via a Novel Mechanism Involving α7 Nicotinic Acetylcholine Receptors
Miriam Melis et al.
JOURNAL OF NEUROSCIENCE (2013)
Nicotine-mediated improvement in L-dopa-induced dyskinesias in MPTP-lesioned monkeys is dependent on dopamine nerve terminal function
Maryka Quik et al.
NEUROBIOLOGY OF DISEASE (2013)
The Pharmacology of L-DOPA-Induced Dyskinesia in Parkinson's Disease
Philippe Huot et al.
PHARMACOLOGICAL REVIEWS (2013)
Nicotine-Induced Structural Plasticity in Mesencephalic Dopaminergic Neurons Is Mediated by Dopamine D3 Receptors and Akt-mTORC1 Signaling
Ginetta Collo et al.
MOLECULAR PHARMACOLOGY (2013)
Nicotine dependence and illness severity in schizophrenia
Rajeev Krishnadas et al.
BRITISH JOURNAL OF PSYCHIATRY (2012)
Impact of Prefrontal Cortex in Nicotine-Induced Excitation of Ventral Tegmental Area Dopamine Neurons in Anesthetized Rats
Die Zhang et al.
JOURNAL OF NEUROSCIENCE (2012)
Nicotine as a potential neuroprotective agent for Parkinson's disease
Maryka Quik et al.
MOVEMENT DISORDERS (2012)
Neuromodulation of Thought: Flexibilities and Vulnerabilities in Prefrontal Cortical Network Synapses
Amy F. T. Arnsten et al.
NEURON (2012)
Low concentrations of nicotine differentially desensitize nicotinic acetylcholine receptors that include α5 or α6 subunits and that mediate synaptosomal neurotransmitter release
Sharon R. Grady et al.
NEUROPHARMACOLOGY (2012)
Anatomical insights into the interaction of emotion and cognition in the prefrontal cortex
Rebecca D. Ray et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2012)
Microglia/Macrophage Polarization Dynamics Reveal Novel Mechanism of Injury Expansion After Focal Cerebral Ischemia
Xiaoming Hu et al.
STROKE (2012)
Glutamate neurocircuitry: theoretical underpinnings in schizophrenia
Thomas L. Schwartz et al.
FRONTIERS IN PHARMACOLOGY (2012)
Nicotine Persistently Activates Ventral Tegmental Area Dopaminergic Neurons via Nicotinic Acetylcholine Receptors Containing α4 and α6 Subunits
Liwang Liu et al.
MOLECULAR PHARMACOLOGY (2012)
Nicotine Reduces L-DOPA-Induced Dyskinesias by Acting at β2*Nicotinic Receptors
Luping Z. Huang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
α6β2*and α4β2*Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson's Disease
Maryka Quik et al.
PHARMACOLOGICAL REVIEWS (2011)
L-DOPA-induced dyskinesia and abnormal signaling in striatal medium spiny neurons: focus on dopamine D1 receptor-mediated transmission
Michael Feyder et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2011)
Current Perspectives on the Selective Regulation of Dopamine D-2 and D-3 Receptors
Dong Im Cho et al.
ARCHIVES OF PHARMACAL RESEARCH (2010)
Poststress treatment with PNU282987 can rescue SH-SY5Y cells undergoing apoptosis via α7 nicotinic receptors linked to a Jak2/Akt/HO-1 signaling pathway
Esther Parada et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Cholinergic protection via alpha 7 nicotinic acetylcholine receptors and PI3K-Akt pathway in LPS-induced neuroinflammation
Ethika Tyagi et al.
NEUROCHEMISTRY INTERNATIONAL (2010)
Multiple roles for nicotine in Parkinson's disease
Maryka Quik et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Nicotinic Receptor-Mediated Neuroprotection in Neurodegenerative Disease Models
Shun Shimohama
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2009)
HCN channels: Structure, cellular regulation and physiological function
C. Wahl-Schott et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
ROLE OF MITOCHONDRIA IN NEURODEGENERATIVE DISEASES: MITOCHONDRIA AS A THERAPEUTIC TARGET IN ALZHEIMER'S DISEASE
P. Hemachandra Reddy
CNS SPECTRUMS (2009)
Update in the epidemiology of Parkinsonʼs disease
Alexis Elbaz et al.
CURRENT OPINION IN NEUROLOGY (2009)
Localized low-level re-expression of high-affinity mesolimbic nicotinic acetylcholine receptors restores nicotine-induced locomotion but not place conditioning
Y. S. Mineur et al.
GENES BRAIN AND BEHAVIOR (2009)
Desensitization of Nicotinic Acetylcholine Receptors as a Strategy for Drug Development
Jerry J. Buccafusco et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission
R. Exley et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Glutamatergic dysfunction in schizophrenia: From basic neuroscience to clinical psychopharmacology
Rodrigo D. Paz et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease
Marina R. Picciotto et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Crucial Role of α4 and α6 Nicotinic Acetylcholine Receptor Subunits from Ventral Tegmental Area in Systemic Nicotine Self-Administration
S. Pons et al.
JOURNAL OF NEUROSCIENCE (2008)
Continuous and intermittent nicotine treatment reduces L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesias in a rat model of Parkinson's disease
Tanuja Bordia et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Long-term nicotine treatment differentially regulates striatal α6α4β2* and α6(nonα4)β2* nAChR expression and function
Xiomara A. Perez et al.
MOLECULAR PHARMACOLOGY (2008)
Tuning of Synaptic Integration in the Medial Entorhinal Cortex to the Organization of Grid Cell Firing Fields
Derek L. F. Garden et al.
NEURON (2008)
Neurochemical pathways involved in the protective effects of nicotine and ethanol in preventing the development of Parkinson's disease: Potential targets for the development of new therapeutic agents
Roberta J. Ward et al.
PROGRESS IN NEUROBIOLOGY (2008)
It is not either/or: Activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood
Marina R. Picciotto et al.
PROGRESS IN NEUROBIOLOGY (2008)
Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys
Maryka Quik et al.
ANNALS OF NEUROLOGY (2007)
The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum
Sharon R. Grady et al.
BIOCHEMICAL PHARMACOLOGY (2007)
The α7 nicotinic receptor agonist 4OH-GTS-21 protects axotomized septohippocampal cholinergic neurons in wild type but not amyloid-overexpressing transgenic mice
K. Ren et al.
NEUROSCIENCE (2007)
Schizophrenia
Marco M. Picchioni et al.
BMJ-BRITISH MEDICAL JOURNAL (2007)
Nigrostriatal damage preferentially decreases a subpopulation of α6β2*nAChRs in mouse, monkey, and Parkinson's disease striatum
Tanuja Bordia et al.
MOLECULAR PHARMACOLOGY (2007)
D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons
D. James Surmeier et al.
TRENDS IN NEUROSCIENCES (2007)
Beyond the dopamine hypothesis to the NMDA glutamate receptor hypofunction hypothesis of schizophrenia
Stephen M. Stahl
CNS SPECTRUMS (2007)
Ablation of D1 dopamine receptor-expressing cells generates mice with seizures, dystonia, hyperactivity, and impaired oral behavior
Ilse Gantois et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
ERK 1/2 signaling pathway is involved in nicotine-mediated neuroprotection in spinal cord neurons
Michal Toborek et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
NMDA receptors and schizophrenia
Lars V. Kristiansen et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity
Andrew B. West et al.
HUMAN MOLECULAR GENETICS (2007)
Kinase activity of mutant LRRK2 mediates neuronal toxicity
Wanli W. Smith et al.
NATURE NEUROSCIENCE (2006)
Mutational analysis of DJ-1 in Drosophila implicates functional inactivation by oxidative damage and aging
Marc C. Meulener et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused inactivation of Drosophila Pink1 is rescued by by Parkin
Yufeng Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Ira E. Clark et al.
NATURE (2006)
Striatal α6* nicotinic acetylcholine receptors:: Potential targets for Parkinson's disease therapy
M Quik et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Brain nicotinic acetylcholine receptors: native subtypes and their relevance
Cecilia Gotti et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Investigating the receptor-independent neuroprotective mechanisms of nicotine in mitochondria
YX Xie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Multiple calcium channels and kinases mediate α7 nicotinic receptor neuroprotection in PC12 cells
K Ren et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors
U Maskos et al.
NATURE (2005)
Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress
RH Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Increased D-1 dopamine receptor signaling in levodopa-induced dyskinesia
I Aubert et al.
ANNALS OF NEUROLOGY (2005)
Mitochondrial dysfunction and oxidative damage in parkin-deficient mice
JJ Palacino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Do we still believe in the dopamine hypothesis? New data bring new evidence
A Abi-Dargham
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2004)
The relationship between brain structure and neurocognition in schizophrenia: a selective review
E Antonova et al.
SCHIZOPHRENIA RESEARCH (2004)
Smoking and Parkinson's disease: Systematic review of prospective studies
MF Allam et al.
MOVEMENT DISORDERS (2004)
Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction
VI Pidoplichko et al.
LEARNING & MEMORY (2004)
Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse
JM Itier et al.
HUMAN MOLECULAR GENETICS (2003)
Decreased dendritic spine density on prefrontal cortical and hippocampal pyramidal neurons in postweaning social isolation rats
AB Silva-Gómez et al.
BRAIN RESEARCH (2003)
Nicotine protects rat brain mitochondria against experimental injuries
A Cormier et al.
NEUROPHARMACOLOGY (2003)
Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats
B Le Foll et al.
SYNAPSE (2003)
Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers
H Kitagawa et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Disruption of nicotine conditioning by dopamine D-3 receptor ligands
B Le Foll et al.
MOLECULAR PSYCHIATRY (2003)
Cholinergic interneuron characteristics and nicotinic properties in the striatum
FM Zhou et al.
JOURNAL OF NEUROBIOLOGY (2002)
Janus kinase 2, an early target of α7 nicotinic acetylcholine receptor-mediated neuroprotection against Aβ-(1-42) amyloid
S Shaw et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Nicotine's oxidative and antioxidant properties in CNS
MB Newman et al.
LIFE SCIENCES (2002)
Relationship between tobacco smoking and positive and negative symptoms in schizophrenia
AA Patkar et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2002)
Smoking and Parkinson's disease in twins
CM Tanner et al.
NEUROLOGY (2002)
Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice
R Xu et al.
MOLECULAR PSYCHIATRY (2002)
Absence of dopamine D4 receptors results in enhanced reactivity to unconditioned, but not conditioned, fear
TL Falzone et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
The Role of Neuronal Nicotinic Acetylcholine Receptors in Acute and Chronic Neurodegeneration
M. J. O'Neill et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2002)
Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum
FM Zhou et al.
NATURE NEUROSCIENCE (2001)
Presynaptic group I and II metabotropic glutamate receptors oppositely modulate striatal acetylcholine release
M Marti et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
α7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block a β-amyloid-induced neurotoxicity
T Kihara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Nicotinic receptor-mediated protection against β-amyloid neurotoxicity
S Shimohama et al.
BIOLOGICAL PSYCHIATRY (2001)
Role of dopamine D1 receptors in the control of striatal acetylcholine release by endogenous dopamine
E Acquas et al.
NEUROLOGICAL SCIENCES (2001)
Dopamine transporter immunoreactivity in peripheral blood lymphocytes in Parkinson's disease
B Caronti et al.
JOURNAL OF NEURAL TRANSMISSION (2001)
The α7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia
R Freedman et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2000)
Distinct functions of the two isoforms of dopamine D2 receptors
A Usiello et al.
NATURE (2000)
Central nicotinic receptors, neurotrophic factors and neuroprotection
N Belluardo et al.
BEHAVIOURAL BRAIN RESEARCH (2000)
α-Bungarotoxin-sensitive nicotinic receptors indirectly modulate [3H]dopamine release in rat striatal slices via glutamate release
S Kaiser et al.
MOLECULAR PHARMACOLOGY (2000)
Smoking and Parkinson's and Alzheimer's disease: review of the epidemiological studies
L Fratiglioni et al.
BEHAVIOURAL BRAIN RESEARCH (2000)
Human post-mortem striatal α4β2 nicotinic acetylcholine receptor density in schizophrenia and Parkinson's syndrome
N Durany et al.
NEUROSCIENCE LETTERS (2000)
Relationship between dopamine D2 occupancy, clinical response, and side effects:: A double-blind PET study of first-episode schizophrenia
S Kapur et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Role of dopamine in the behavioural actions of nicotine related to addiction
G Di Chiara
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
分享论文
